$693 Million is the total value of Iron Triangle Partners LP's 27 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was 88.5% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SNY | Buy | SANOFIsponsored adr | $64,201,233 | +103.9% | 1,179,736 | +81.5% | 9.26% | +64.1% |
| ABBV | New | ABBVIE INC | $50,998,400 | – | 320,000 | +100.0% | 7.36% | – |
| ICLR | Sell | ICON PLC | $40,582,100 | -7.1% | 190,000 | -15.6% | 5.85% | -25.3% |
| DXCM | Buy | DEXCOM INC | $39,501,200 | +190.5% | 340,000 | +183.1% | 5.70% | +133.7% |
| UNH | New | UNITEDHEALTH GROUP INC | $37,807,200 | – | 80,000 | +100.0% | 5.45% | – |
| ACHC | Buy | ACADIA HEALTHCARE COMPANY IN | $37,043,009 | +125.0% | 512,706 | +156.4% | 5.34% | +81.0% |
| GILD | Buy | GILEAD SCIENCES INC | $34,847,400 | +8.7% | 420,000 | +12.4% | 5.03% | -12.6% |
| EVH | New | EVOLENT HEALTH INCcl a | $32,463,045 | – | 1,000,402 | +100.0% | 4.68% | – |
| COO | Sell | COOPER COS INC | $31,735,600 | -22.0% | 85,000 | -30.9% | 4.58% | -37.2% |
| ISRG | Buy | INTUITIVE SURGICAL INC | $30,656,400 | +65.0% | 120,000 | +71.4% | 4.42% | +32.8% |
| ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $28,789,500 | +7.7% | 425,000 | +4.4% | 4.15% | -13.3% |
| SGRY | Sell | SURGERY PARTNERS INC | $28,112,077 | -21.2% | 815,552 | -36.3% | 4.06% | -36.6% |
| PACB | Buy | PACIFIC BIOSCIENCES CALIF IN | $26,634,000 | +91.5% | 2,300,000 | +35.3% | 3.84% | +54.1% |
| CRL | Sell | CHARLES RIV LABS INTL INC | $26,236,600 | -39.8% | 130,000 | -35.0% | 3.78% | -51.6% |
| IDXX | New | IDEXX LABS INC | $25,004,000 | – | 50,000 | +100.0% | 3.61% | – |
| LEGN | New | LEGEND BIOTECH CORPsponsored ads | $24,110,000 | – | 500,000 | +100.0% | 3.48% | – |
| SRPT | Buy | SAREPTA THERAPEUTICS INC | $22,052,800 | +57.9% | 160,000 | +48.5% | 3.18% | +27.1% |
| TXG | New | 10X GENOMICS INC | $19,526,500 | – | 350,000 | +100.0% | 2.82% | – |
| INSP | Sell | INSPIRE MED SYS INC | $16,384,900 | -18.7% | 70,000 | -12.5% | 2.36% | -34.6% |
| SDGR | New | SCHRODINGER INC | $15,684,702 | – | 595,697 | +100.0% | 2.26% | – |
| CUTR | New | CUTERA INC | $14,172,000 | – | 600,000 | +100.0% | 2.04% | – |
| MASS | Buy | 908 DEVICES INC | $9,030,000 | +35.5% | 1,050,000 | +20.0% | 1.30% | +9.0% |
| OLK | New | OLINK HLDG ABsponsored ads | $9,012,000 | – | 400,000 | +100.0% | 1.30% | – |
| New | 2SEVENTY BIO INC | $8,863,178 | – | 868,939 | +100.0% | 1.28% | – | |
| SWTX | New | SPRINGWORKS THERAPEUTICS INC | $8,047,971 | – | 312,664 | +100.0% | 1.16% | – |
| BKD | New | BROOKDALE SR LIVING INC | $7,965,000 | – | 2,700,000 | +100.0% | 1.15% | – |
| STXS | Buy | STEREOTAXIS INC | $3,738,457 | +8.1% | 1,832,577 | +9.7% | 0.54% | -13.1% |
| KPTI | Exit | KARYOPHARM THERAPEUTICS INC | $0 | – | -1,926,782 | -100.0% | -1.18% | – |
| RXDX | Exit | PROMETHEUS BIOSCIENCES INC | $0 | – | -75,000 | -100.0% | -1.48% | – |
| Exit | AMYLYX PHARMACEUTICALS INC | $0 | – | -240,240 | -100.0% | -1.59% | – | |
| SNDX | Exit | SYNDAX PHARMACEUTICALS INC | $0 | – | -370,294 | -100.0% | -1.69% | – |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -100,089 | -100.0% | -2.14% | – |
| NARI | Exit | INARI MED INC | $0 | – | -190,000 | -100.0% | -2.16% | – |
| CI | Exit | CIGNA CORP NEW | $0 | – | -60,000 | -100.0% | -3.56% | – |
| UTHR | Exit | UNITED THERAPEUTICS CORP DEL | $0 | – | -71,576 | -100.0% | -3.57% | – |
| BSX | Exit | BOSTON SCIENTIFIC CORP | $0 | – | -600,000 | -100.0% | -4.98% | – |
| RGEN | Exit | REPLIGEN CORP | $0 | – | -178,000 | -100.0% | -5.40% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -300,000 | -100.0% | -7.58% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-15
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| HORIZON THERAPEUTICS PUB LTD | 12 | Q3 2022 | 9.0% |
| GUARDANT HEALTH INC | 12 | Q3 2022 | 6.1% |
| CHARLES RIV LABS INTL INC | 11 | Q1 2023 | 7.8% |
| SURGERY PARTNERS INC | 11 | Q2 2023 | 6.4% |
| ICON PLC | 10 | Q3 2023 | 11.7% |
| BOSTON SCIENTIFIC CORP | 10 | Q3 2023 | 8.9% |
| NEVRO CORP | 10 | Q1 2022 | 6.7% |
| DEXCOM INC | 10 | Q3 2023 | 7.7% |
| ABBVIE INC | 9 | Q3 2023 | 8.1% |
| ACADIA HEALTHCARE COMPANY IN | 9 | Q3 2023 | 7.9% |
View Iron Triangle Partners LP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-15 |
View Iron Triangle Partners LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.